ESPERA study: Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice-Reference-Cited by-同舟云学术

ESPERA study: Applicability of the new ILAE criteria for antiepileptic drug resistance of focal epilepsies in current clinical practice

Published:2012-10 Issue:2 Volume:25 Page:166-169
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

de Toffol Bertrand,de Zélicourt Marie,Vespignani Hervé,Fagnani Francis,Laurendeau Caroline,Lévy-Bachelot Laurie,Murat Christina,Gasalla Teresa,Arzimanoglou Alexis,Villanueva Vicente

Funder

The French League Against Epilepsy (LFCE)

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference7 articles.

1. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies;Kwan;Epilepsia,2010

2. Defining intractability: comparisons among published definitions;Berg;Epilepsia,2006

3. Drug-resistant epilepsy;Kwan;N Engl J Med,2011

4. Treating refractory epilepsy in adults;Reynolds;BMJ,2006

5. Risk of recurrence after a first unprovoked seizure;Berg;Epilepsia,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of focal epilepsy in adults treated with polytherapy in France: The direct cost of drug resistance (ESPERA study);Seizure;2014-05

2. Patients adultes traités par une association d’antiépileptiques pour une épilepsie focale en France : description et mode de prise en charge selon les nouveaux critères de définition de la pharmacorésistance (étude ESPERA);Revue Neurologique;2014-02

3. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment;Nature Communications;2013-09-03